Bristol-Myers Squibb Company
BMY
New York Stock Exchange. Currency in USD
73.16 -0.33 ( -0.45% )
Market Cap.
155.55B
Beta (5Y monthly)
0.39
Price/Earnings
10.36
EPS (TTM)
7.71
Forward Dividend
2.28 (2.96%)
Ex-Dividend Date
Jan 05, 2023
Volume
8.04M
1y Target Est.
80.67
Day's Range
52 Week's Range
Historical Summary
Performance
1 Month
-5.54%
YTD
17.34%
1Y
18.84%
2Y
15.91%
7.67% ann.
3Y
16.40%
5.19% ann.
5Y
18.84%
3.51% ann.
10Y
124.62%
8.43% ann.
EPS growth
1Y
8.13%
2Y
24.35%
11.52% ann.
3Y
75.63%
20.65% ann.
5Y
160.47%
21.11% ann.
10Y
281.68%
14.33% ann.
20Y
384.91%
8.21% ann.
Share Buybacks
3 Months
-0.00%
6 Months
0.69%
1Y
4.19%
2Y
6.16%
3Y
-31.52%
5Y
-30.64%
10Y
-28.99%
20Y
-10.72%
About Bristol-Myers Squibb Company
Sector
Healthcare
Industry
Drug Manufacturers-General
Website
https://www.bms.com
Exchange
New York Stock Exchange (XNYS)
Shares Outstanding
2.22B
Employees
32200
Address
430 East 29th Street, New York, NY, United States, 10016
Latest news

My 3 Best Stocks of 2022 -- and Why I Think They'll Win Again in 2023
The momentum for these high-flying stocks should continue in the new year.
By The Motley Fool - 6 weeks ago

6 Stocks Warren Buffett Completely Exited in 2022
Despite being an active buyer this year, Buffett's company Berkshire Hathaway also sold several of...
By The Motley Fool - 6 weeks ago

2 Dividend Stocks to Buy and Hold Through 2023 and Beyond
These pharma giants are crushing the broader market this year.
By The Motley Fool - 7 weeks ago

Bristol Myers Squibb Company (BMY) Is a Trending Stock: Facts to Know Before Betting on It
Zacks.com users have recently been watching Bristol Myers (BMY) quite a bit. Thus, it is...
By Zacks Investment Research - 7 weeks ago

Mirati (MRTX) Up on FDA Nod to Adagrasib for KRAS Mutated NSCLC
The accelerated approval of Mirati Therapeutics' (MRTX) Krazati is based on ORR and DOR data...
By Zacks Investment Research - 7 weeks ago

Bristol Myers Squibb (BMY) Gains But Lags Market: What You Should Know
Bristol Myers Squibb (BMY) closed the most recent trading day at $78.89, moving +0.08% from...
By Zacks Investment Research - 7 weeks ago

The Zacks Analyst Blog Highlights Merck, Bristol-Myers Squibb and Deere
Merck, Bristol-Myers Squibb and Deere are included in this Analyst Blog.
By Zacks Investment Research - 7 weeks ago

Dividend Champion, Contender, And Challenger Highlights: Week Of December 11
Weekly summary of dividend activity for Dividend Champions, Contenders, Challengers. Read more to see companies...
By Seeking Alpha - 7 weeks ago